- Clinical Trials
- January 2024
- 60 Pages
Global
From €1199EUR$1,250USD£1,000GBP
Non-selective COX inhibitors are a type of analgesic, or pain reliever, that work by blocking the enzyme cyclooxygenase (COX). This enzyme is responsible for the production of prostaglandins, which are molecules that cause inflammation and pain. By blocking the enzyme, non-selective COX inhibitors reduce inflammation and pain. They are used to treat a variety of conditions, including arthritis, headaches, and menstrual cramps. Non-selective COX inhibitors are generally considered to be more effective than other types of analgesics, but they can also cause more side effects.
Some of the companies in the non-selective COX inhibitors market include Pfizer, Merck, GlaxoSmithKline, and Bayer. Show Less Read more